Table of Contents

|Articles|November 1, 2003

Pharmaceutical Executive

Pharmaceutical Executive-11-01-2003

Table of Contents

External Link - article-75642.pdf

Articles in this issue

over 22 years ago

Article

The Ten Billion Dollar Molecule

over 22 years ago

Article

The Path to Smart R&D

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Articles in this issue

Related Content

Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma

Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

The New Healthy Aging Imperative and What It Means for Pharma

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Trending on PharmExec

The New Healthy Aging Imperative and What It Means for Pharma

Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma